Ketorolac Tromethamine



Ketorolac Tromethamine





(kee’ toe role ak)

Acular LS, Acuvail, Apo-Ketorolac (CAN), Apo-Ketorolac Injectable (CAN), Ketorolac (CAN), Sprix, Toradol (CAN), Tromethamine Injection (CAN)

PREGNANCY CATEGORY C

(FIRST AND SECOND TRIMESTERS)

PREGNANCY CATEGORY D

(THIRD TRIMESTER)


Drug Classes

Antipyretic

Nonopioid analgesic

NSAID


Therapeutic Actions

Anti-inflammatory and analgesic activity; inhibits prostaglandins and leukotriene synthesis.


Indications



  • Short-term management of pain (up to 5 days)


  • Ophthalmic: Relief of ocular itching due to seasonal conjunctivitis and relief of postoperative inflammation and pain after cataract surgery



Available Forms

Ophthalmic solution—0.4%, 0.45%, 0.5%; tablets—10 mg; injection—15 mg/mL, 30 mg/mL, 60 mg/2 mL, 300 mg/100 mL; nasal spray—15.75 mg/spray


Dosages

For short-term use only (up to 5 days). Potent NSAID with many adverse effects.

Adults

Parenteral



  • Single-dose treatment: 60 mg IM or 30 mg IV.


  • Multiple-dose treatment: 30 mg IM or IV every 6 hr to a maximum 120 mg/day.

Oral



  • Transfer to oral: 20 mg PO as a first dose for patients who received 60 mg IM or 30 mg IV as a single dose or 30-mg multiple dose, followed by 10 mg every 4–6 hr; do not exceed 40 mg/24 hr.

Nasal spray



  • Patients younger than 65 yr: 1 spray (15.75 mg) in each nostril every 6–8 hr; maximum daily dose, 126 mg.


  • Patients 65 yr and older, patients with renal impairment, and patients weighing less than 50 kg: 1 spray in one nostril every 6–8 hr; maximum daily dose, 63 mg.

Ophthalmic

Jul 21, 2016 | Posted by in NURSING | Comments Off on Ketorolac Tromethamine

Full access? Get Clinical Tree

Get Clinical Tree app for offline access